查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829308

2025年全球心血管植入市场报告

Cardiovascular Implants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心血管植入市场规模强劲成长，从2024年的268亿美元增加至2025年的286.8亿美元，复合年增长率为7.0%。预测期内的成长归因于人口老化、心血管风险的增加、生活方式相关的心血管风险因素、诊断技术的改进、认知度的提高和筛检计画的推进，以及政府在心血管健康方面的倡议。

预计未来几年心血管植入市场将强劲成长，到2029年将达到367.6亿美元，复合年增长率为6.4%。预测期内的成长归因于个人化医疗方法、对年复合成长率手术的关注、心血管研究的全球合作、强调预防性干预的医疗保健政策以及以患者为中心的心血管护理。预测期内的主要趋势包括药物释放型支架的进步、下一代心臟瓣膜的兴起、人工智慧 (AI) 整合度的提高、对微创植入手术的关注，以及个人化、患者专用植入和无导线起搏器的开发。

心血管植入是透过手术植入心血管系统，用于治疗心臟和血管疾病的医疗设备。这些器械被策略性地植入心血管系统，以治疗动脉阻塞、心律不整和瓣膜缺陷等疾病。其主要目标是恢復正常的心臟功能并改善血液循环。

心血管植入的主要产品类型包括冠状动脉支架、植入式心臟整流去颤器(ICD)、心臟瓣膜、植入式心臟节律器、心臟再同步治疗 (CRT) 装置以及週边支架。冠状动脉支架是插入狭窄或阻塞的冠状动脉以保持其畅通的小网状管。製造这些植入的材料多种多样，包括金属和合金、聚合物和生物材料。其应用包括治疗心律不整、急性心肌梗塞和心肌缺血。这些心血管植入的最终用户包括医院、门诊手术中心和心臟中心等各种机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供心血管植入市场统计数据，包括全球市场规模、区域份额、竞争对手的心血管植入市场份额、详细的心血管植入细分市场、市场趋势和商机，以及您在心血管植入行业取得成功所需的数据。本心血管植入市场研究报告对该行业的现状和未来趋势进行了详细分析，植入您提供所需的一切观点。

我们预测未来五年该市场将成长6.4%，较先前预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自义大利和瑞典等主要地区的钴铬合金环和聚合物瓣环成形带环状成形术关税直接影响美国，这可能导致结构性心臟介入治疗成本增加和瓣膜修復手术延误。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

预计心臟病患病率的上升将在未来几年推动心血管植入市场的成长。心臟病包括影响心臟和血管的各种疾病，例如冠状动脉疾病、心臟衰竭、心律不整和瓣膜疾病。冠状动脉疾病和心臟衰竭等心臟病的增加推动了对包括支架和心臟衰竭在内的心血管植入的需求。这些植入支持心臟衰竭患者的心臟功能和血液循环，调节心律并监测心臟活动。例如，2024 年 9 月，英国心臟基金会 (BHF) 报告称，英国约有 760 万人患有心臟和循环系统疾病，BHF 是一家总部位于英国的慈善机构，致力于资助和提高人们对心臟和循环系统疾病研究的认识。到 2030 年，这个数字可能会增加 100 万，到 2040 年再增加 200 万。因此，心臟病患病率的上升正在推动心血管植入市场的发展。

预计未来几年，老龄化人口的不断增长将推动心血管植入市场的成长。人口老化反映了一种人口结构变化，其特征是60岁及以上人口比例的上升。心血管植入在管理和治疗老年人常见的心血管疾病方面发挥关键作用，有助于改善生活品质、延长寿命并改善整体健康。根据世界卫生组织（WHO）2022年10月的数据，预计到2030年，全球整体六分之一的人口将达到60岁及以上，到2050年，这一数字将达到21亿。因此，老龄化人口的不断增长是推动心血管植入市场成长的关键因素。

心血管植入市场的主要企业越来越注重整合包括人工智慧 (AI) 在内的先进技术，以优化市场利润并改善患者的治疗和护理。心臟监测技术的进步包括持续追踪和记录患者的心臟活动，以诊断和管理心臟疾病。 2023 年 6 月，BIOTRONIK SE & Co. KG 推出了 BIOMONITOR IV，这是世界上第一款将 SmartECG 技术与人工智慧结合的植入式心臟监测器 (ICM)。这项技术创新将误报率降低了 86%，同时在检测实际发作方面保持了 98% 的准确率。 BIOMONITOR IV 还具有其他优势，包括更长的电池寿命和无线连接，可实现无缝资料传输和远端监控，从而减少了频繁就诊的需求。

2023年4月，雅培实验室以8.9亿美元收购了心血管系统公司（Cardiovascular Systems Inc.），以增强其血管疾病治疗解决方案。此次策略性收购使心血管系统公司完全子公司，并巩固了雅培在提供週边血管和冠状动脉疾病创新解决方案方面的地位。

心血管植入市场包括动脉瘤支架血管支架、心臟再同步治疗 (CRT) 装置、心室辅助人工心臟和周边支架的销售。该市场的价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心血管植入：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球心血管植入市场：成长率分析
  • 全球心血管植入市场表现：规模与成长，2019-2024
  • 全球心血管植入市场预测：2024-2029年及2034年规模与成长
  • 全球心血管植入：总目标市场（TAM）

第六章 市场细分

  • 全球心血管植入市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 冠状动脉支架
  • 植入式心臟整流去颤器（ICD）
  • 心臟瓣膜
  • 植入式心臟节律器
  • 心臟再同步治疗 (CRT) 设备
  • 外周支架
  • 全球心血管植入市场：按材料、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 金属和合金
  • 聚合物
  • 生物材料
  • 全球心血管植入市场：应用、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 心律不整
  • 急性心肌梗塞
  • 心肌缺血
  • 其他用途
  • 全球心血管植入市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 心臟中心
  • 全球心血管植入市场：细分：冠状动脉支架（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物释放型支架
  • 裸金属支架
  • 生物可吸收支架
  • 全球心血管植入市场：植入式心臟整流去颤器(ICD) 细分，类型，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔ICD
  • 双腔ICD
  • 双心室ICD
  • 全球心血管植入市场：依心臟瓣膜类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 人工心臟瓣膜
  • 生物心臟瓣膜
  • 经导管心臟瓣膜
  • 全球心血管植入市场：植入式心臟节律器细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔起搏器
  • 双腔起搏器
  • 双心室节律器
  • 全球心血管植入市场：心臟再同步治疗 (CRT) 设备细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • CRT-P 设备（心律调节器）
  • CRT-D 装置（去心房颤动）
  • 全球心血管植入市场：週边支架细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 颈动脉支架
  • 肾动脉支架
  • 股动脉支架

第七章 区域和国家分析

  • 全球心血管植入市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年及 2034 年）
  • 全球心血管植入市场：各国市场表现及预测（2019-2024年、2024-2029年、2034年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 心血管植入市场：竞争格局
  • 心血管植入市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • WL Gore & Associates Inc.
  • Cook Medical Incorporated
  • Teleflex Incorporated
  • Kyoto Medical Planning Co. Ltd.
  • Abiomed Inc.
  • Livanova PLC
  • BIOTRONIK SE & Co. KG
  • CryoLife Inc.
  • Endologix Inc.
  • Sorin Group
  • Berlin Heart GmbH
  • REVA Medical LLC.
  • Syncardia Systems LLC
  • Elixir Medical Corporation
  • Fortimedix Surgical BV

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年心血管植入市场：提供新机会的国家
  • 2029年心血管植入市场：细分领域带来新机会
  • 2029年心血管植入市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r27629u

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $26.8 billion in 2024 to $28.68 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to aging population and cardiovascular risk, lifestyle-related cardiovascular risk factors, improvements in diagnostic technologies, growing awareness and screening programs, government initiatives for cardiovascular health.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $36.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to personalized medicine approaches, focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, patient-centric cardiovascular care. Major trends in the forecast period include advancements in drug-eluting stents, rise of next-generation heart valves, increasing integration of artificial intelligence (ai), focus on minimally invasive implantation techniques, personalized and patient-specific implants, development of leadless pacemakers.

The forecast of 6.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on cobalt-chromium alloy rings and polymer-based annuloplasty bands, sourced from key regions such as Italy and Sweden, which could lead to increased costs for structural heart interventions and potential delays in valve repair procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.

The increase in the aging population is expected to drive the growth of the cardiovascular implants market in the future. The aging population reflects a demographic shift characterized by a higher proportion of individuals aged 60 and above in a population. Cardiovascular implants play a crucial role in managing and treating cardiovascular diseases prevalent in older individuals, contributing to improved quality of life, increased longevity, and overall better health outcomes. According to the World Health Organization in October 2022, globally, 1 in 6 individuals is projected to be 60 or older by 2030, and this number is expected to reach 2.1 billion elderly people by 2050. Therefore, the rise in the aging population is a key factor driving the growth of the cardiovascular implants market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents
  • 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
  • 3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
  • 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
  • 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
  • 6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; Cook Medical Incorporated; Teleflex Incorporated; Kyoto Medical Planning Co. Ltd.; Abiomed Inc.; Livanova PLC; BIOTRONIK SE & Co. KG; CryoLife Inc.; Endologix Inc.; Sorin Group; Berlin Heart GmbH; REVA Medical LLC.; Syncardia Systems LLC; Elixir Medical Corporation; Fortimedix Surgical B.V.; AMG International GmbH; CHF Solutions Inc.; Proxy Biomedical Ltd.; Calon Cardio-Technology Ltd.; InspireMD Inc.; Neovasc Inc.; Shree Pacetronix Ltd.; Vascutek Ltd (Terumo Corporation)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular Implants Market Characteristics

3. Cardiovascular Implants Market Trends And Strategies

4. Cardiovascular Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiovascular Implants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiovascular Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiovascular Implants Market Growth Rate Analysis
  • 5.4. Global Cardiovascular Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiovascular Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiovascular Implants Total Addressable Market (TAM)

6. Cardiovascular Implants Market Segmentation

  • 6.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Stent
  • Implantable Cardioverter Defibrillator (ICD)
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Peripheral Stent
  • 6.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metals and Alloys
  • Polymers
  • Biological Materials
  • 6.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arrhythmias
  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Other Applications
  • 6.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • 6.5. Global Cardiovascular Implants Market, Sub-Segmentation Of Coronary Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioabsorbable Stents
  • 6.6. Global Cardiovascular Implants Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber ICD
  • Dual-Chamber ICD
  • Biventricular ICD
  • 6.7. Global Cardiovascular Implants Market, Sub-Segmentation Of Heart Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Heart Valves
  • Biological Heart Valves
  • Transcatheter Heart Valves
  • 6.8. Global Cardiovascular Implants Market, Sub-Segmentation Of Implanted Cardiac Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemaker
  • Dual-Chamber Pacemaker
  • Biventricular Pacemaker
  • 6.9. Global Cardiovascular Implants Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT) Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P Devices (Pacemakers)
  • CRT-D Devices (Defibrillators)
  • 6.10. Global Cardiovascular Implants Market, Sub-Segmentation Of Peripheral Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carotid Artery Stents
  • Renal Artery Stents
  • Femoral Artery Stents

7. Cardiovascular Implants Market Regional And Country Analysis

  • 7.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiovascular Implants Market

  • 8.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiovascular Implants Market

  • 9.1. China Cardiovascular Implants Market Overview
  • 9.2. China Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiovascular Implants Market

  • 10.1. India Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiovascular Implants Market

  • 11.1. Japan Cardiovascular Implants Market Overview
  • 11.2. Japan Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiovascular Implants Market

  • 12.1. Australia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiovascular Implants Market

  • 13.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiovascular Implants Market

  • 14.1. South Korea Cardiovascular Implants Market Overview
  • 14.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiovascular Implants Market

  • 15.1. Western Europe Cardiovascular Implants Market Overview
  • 15.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiovascular Implants Market

  • 16.1. UK Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiovascular Implants Market

  • 17.1. Germany Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiovascular Implants Market

  • 18.1. France Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiovascular Implants Market

  • 19.1. Italy Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiovascular Implants Market

  • 20.1. Spain Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiovascular Implants Market

  • 21.1. Eastern Europe Cardiovascular Implants Market Overview
  • 21.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiovascular Implants Market

  • 22.1. Russia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiovascular Implants Market

  • 23.1. North America Cardiovascular Implants Market Overview
  • 23.2. North America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiovascular Implants Market

  • 24.1. USA Cardiovascular Implants Market Overview
  • 24.2. USA Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiovascular Implants Market

  • 25.1. Canada Cardiovascular Implants Market Overview
  • 25.2. Canada Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiovascular Implants Market

  • 26.1. South America Cardiovascular Implants Market Overview
  • 26.2. South America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiovascular Implants Market

  • 27.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiovascular Implants Market

  • 28.1. Middle East Cardiovascular Implants Market Overview
  • 28.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiovascular Implants Market

  • 29.1. Africa Cardiovascular Implants Market Overview
  • 29.2. Africa Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 30.1. Cardiovascular Implants Market Competitive Landscape
  • 30.2. Cardiovascular Implants Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiovascular Implants Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Cook Medical Incorporated
  • 31.3. Teleflex Incorporated
  • 31.4. Kyoto Medical Planning Co. Ltd.
  • 31.5. Abiomed Inc.
  • 31.6. Livanova PLC
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. CryoLife Inc.
  • 31.9. Endologix Inc.
  • 31.10. Sorin Group
  • 31.11. Berlin Heart GmbH
  • 31.12. REVA Medical LLC.
  • 31.13. Syncardia Systems LLC
  • 31.14. Elixir Medical Corporation
  • 31.15. Fortimedix Surgical B.V.

32. Global Cardiovascular Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiovascular Implants Market

34. Recent Developments In The Cardiovascular Implants Market

35. Cardiovascular Implants Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiovascular Implants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiovascular Implants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiovascular Implants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer